To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

SYDNEY, Apr 24 (Reuters) Gold took a rollercoaster ride on Monday as investors first lapped up bullion then sold out, sending prices down more than 2 percent to $623.50 a ounce.

A weak dollar first pulled more money into gold before easing oil prices took some of the worry out of inflation concerns, prompting a wave of bullion sales, dealers said.

''Gold was up, but just as quickly seemed to come off,'' one said.

A range of investment and private funds -- increasingly seeing gold as a hedge against the depreciation of the dollar, particularly as rising oil prices spell higher inflation -- have pushed prices up as much as 25 percent this year.

Gold raced has high as $639.00 on Monday versus versus $632 in late New York trade on Friday before dropping to an intraday low of $623.10. At 0518 GMT, spot gold cost $624.10/$624.90 an ounce.

''It's not the biggest of moves, but we are seeing some profit taking after gold opened higher here,'' Commonwealth Bank of Australia commodities analyst Tobin Gorin said.

''Gold opened at $638.75 in Sydney, building on a rise of 5.1 percent in price last week.

Lower oil prices wiped away some inflationary concerns, souring some investors to gold in the process, dealers said.

Merrill Lynch analyst Michael Jalonen said in a client note that in the short term the gold market should ''gain confidence by virtue of holding above the $600 an ounce level.'' Silver also slid after initially gaining about 17 cents, later trading at around $12.72/$12.82 an ounce versus $13.10 earlier.

Silver prices have soared as much as 50 percent this year, hitting $14.68 last Thursday on expectations an exchange-traded fund under review will boost demand, which has waned as jewellery and film photography is replaced with digital technology.

The metal is used in photographic paper and film. Up to 5,000 colour photos can be taken using an ounce of silver.

Barclays Global Investors, which plans to list the fund, is awaiting regulatory approval from the U.S. Securities and Exchange Commission.

Both metals gained in the final Comex session last week, when precious metals recovered some ground after a widespread sell-off the previous day as speculators seeking profits found prices too high to resist.

''At those levels, there was money to be made by selling,'' another dealer said.

Platinum dropped 17 to $1,105/$1,110 an ounce versus $1,125/1,130 in New York.

Palladium dropped $3 to $352/357.00.

REUTERS CS PM1501

Bird flu cases multiply around Pakistani capital

Islamabad, Apr 24 : Pakistan reported mounting cases of the deadly H5NI bird flu virus today after discovering more infected farms close to Islamabad.''Now, we have total nine poultry farms (near Islamabad) where H5N1 virus has been confirmed,'' Mohammad Afzal, the ministry's livestock commissioner, told Reuters.He said more than 40,000 chickens had been culled after new outbreaks were discovered in the past week at eight farms located in Tarlai and Sihala, two areas near Islamabad where poultry farms are.....

Four die in Sri Lanka violence, ethnic fears rise

COLOMBO, Apr 24: Four people were shot dead in fresh Sri Lankan violence today, while the killing of six Sinhalese farmers by suspected Tamil Tiger rebels the previous day raised fears of more ethnic riots.Some 100 people have died in just over two weeks after a series of suspected Tamil Tiger ambushes on the military were followed by attacks on Tamil civilians.Both sides say they are still working towards talks that were scheduled for last week in Switzerland,.....

Novartis Q1 sales shy but profit beats expectations

ZURICH, Apr 24 (Reuters) Swiss drugmaker Novartis AG reported weaker first-quarter sales than expected on Monday as its generics division disappointed, but profits swelled thanks to a chunky one-off gain from the sale of a unit. Sales at the company's pharmaceuticals division rose 9 percent to $5.052 billion, shy of a forecast of $5.132 billion on average in a Reuters poll of analysts, despite strong double-digit percentage growth in cancer and heart drugs. Novartis's.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login